Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Roopal P. Luhana Appointed to Plaintiffs' Executive Committee for Paraquat MDL
  • USA - English

Chaffin Luhana Founder Appointed to Leadership Role In National Paraquat Litigation


News provided by

Chaffin Luhana LLP

Jul 09, 2021, 08:00 ET

Share this article

Share toX

Share this article

Share toX

NEW YORK, July 9, 2021 /PRNewswire-PRWeb/ -- Chaffin Luhana LLP, a national plaintiffs-only law firm, is pleased to announce that Founding Partner Roopal P. Luhana has been appointed by Chief U.S. District Judge Nancy J. Rosenstengel to the Plaintiffs' Executive Committee (PEC) in the In re: Paraquat Products Liability Litigation.

The Paraquat MDL was established by the U.S. Judicial Panel on Multidistrict Litigation (JPML) on June 6, 2021. All federally filed Paraquat lawsuits are now consolidated (and future federal cases will be transferred) to Judge Rosenstengel in the U.S. District Court for the Southern District of Illinois, where pre-trial proceedings will take place under MDL No. 3004.

"I am honored to be chosen by Judge Rosenstengel to help lead this important litigation on behalf of plaintiffs whose lives have been forever altered after exposure to Paraquat and feel this really is a recognition of the exemplary work the women and men in our law firm do every day for all of our clients," said Ms. Luhana. "My firm and I believe that those responsible for our clients' suffering should be held accountable and we are ready to take on that fight."

Ms. Luhana has served on a number of steering committees in important litigations over the past decade, including most recently having been appointed by U.S. District Judge Robin L. Rosenberg to the Plaintiffs' Steering Committee (PSC) in the In re: Zantac (Ranitidine) Products Liability Litigation (S.D.FL.).

"Part of Chaffin Luhana's mission is to lead in industry-impacting litigations as we have done for over a decade, and Ms. Luhana's appointment is yet another opportunity to do so," says Chaffin Luhana Managing Partner, Eric Chaffin. "The Court has set the first trial for fall of 2022, and we are eager to get this case in front of a jury."

Presently, there are over 90 paraquat lawsuits that have been filed in various courts across the country. Paraquat, a commonly used herbicide in the U.S. and around the world, has been the focus of growing concern over its potential link to negative health effects, including Parkinson's disease (PD). Recent studies have suggested that people exposed to the herbicide may have a higher risk of PD, particularly those who were exposed to it for long periods.

In July of 2017, the Unified Parkinson's Advocacy Council submitted a letter to the Environmental Protection Agency (EPA) in which it noted, "Recent research links paraquat and several other herbicides to the development of Parkinson's pathology and symptoms." In the letter, the Unified Parkinson's Advocacy Council urged the EPA to ban the use of the herbicide in the U.S., which the agency has not done as of the posting of this press release.

Chaffin Luhana is currently investigating cases in which clients used paraquat and then were diagnosed with PD or other similar health problems. For more information, please visit ChaffinLuhana.com.

About Chaffin Luhana

Chaffin Luhana LLP is a plaintiffs-only national trial firm focused on representing injured survivors and their families in catastrophic and complex cases. Started by former federal prosecutor Eric Chaffin and Roopal Luhana, the firm is comprised of former state and federal prosecutors, former large defense firm attorneys, former judicial law clerks, and caring and compassionate staff including an in-house social worker. The firm has been appointed by federal and state courts to important national litigations including the 3T Heater-Cooler Litigation, the Transvaginal Mesh Litigation, the Yaz Birth Control Litigation, and the Denture Cream Zinc Poisoning Litigation, among others. Notably, Ms. Luhana was recently appointed to the Plaintiffs' Steering Committee (PSC) in the Zantac (Ranitidine) Products Liability Litigation (S.D.FL.). With over 130 years of combined legal experience, Chaffin Luhana's attorneys have recovered over $1 billion for their clients nationwide.

If you or a loved one has suffered an injury or death due to an accident, dangerous medication, defective medical device, or faulty product, contact Chaffin Luhana LLP for a free and confidential case review at 888-480-1123, or visit their website at https://www.chaffinluhana.com/. 

**Attorney Advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Media Contact

Dan Reo, Chaffin Luhana LLP, +1 (888) 480-1123, [email protected]

SOURCE Chaffin Luhana LLP

Related Links

http://www.chaffinluhana.com/

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.